CHIT1 and Alzheimer disease: Otherwise, the heterozygotes for the 24-bp duplication showed significantly reduced levels of CHIT1 in comparison with the non-carriers in both FTD and controls but not in prion disease and AD (Table 2, Fig. 1b).